Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

NCT06698679 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT06698679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06698679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 15, 2024
Completion date
October 31, 2031
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer